Cargando…

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma

Recently, long non-coding RNAs (lncRNAs) were found to be implicated in cancer progression. However, the contributions of lncRNAs to Hepatitis C virus-related hepatocellular carcinoma (HCC) remain largely unknown. Here, we characterized lncRNA expression in 73 tissue samples from several different d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Haohai, Zhu, Chengpei, Zhao, Yi, Li, Ming, Wu, Liangcai, Yang, Xiaobo, Wan, Xueshuai, Wang, Anqiang, Zhang, Michael Q., Sang, Xinting, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791265/ https://www.ncbi.nlm.nih.gov/pubmed/26540467

Ejemplares similares

Coffee and cancer risk: A meta-analysis of prospective observational studies
por: Wang, Anqiang, et al.
Publicado: (2016)

Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016)

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma
por: Li, Guangbing, et al.
Publicado: (2014)

Citrus Fruit Intake Substantially Reduces the Risk of Esophageal Cancer: A Meta-Analysis of Epidemiologic Studies
por: Wang, Anqiang, et al.
Publicado: (2015)

Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct
por: Wan, Xueshuai, et al.
Publicado: (2017)

Clinicopathological Features of Gallbladder Papillary Adenocarcinoma
por: Wan, Xueshuai, et al.
Publicado: (2014)

Dr.VIS v2.0: an updated database of human disease-related viral integration sites in the era of high-throughput deep sequencing
por: Yang, Xiaobo, et al.
Publicado: (2014)

A new avenue for obtaining insight into the functional characteristics of long noncoding RNAs associated with estrogen receptor signaling
por: Wu, Liangcai, et al.
Publicado: (2016)

Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing
por: Zheng, Yongchang, et al.
Publicado: (2017)

Brain metastases from hepatocellular carcinoma: recent advances and future avenues
por: Wang, Shanshan, et al.
Publicado: (2017)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
por: Long, Junyu, et al.
Publicado: (2017)

Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression
por: Lin, Jianzhen, et al.
Publicado: (2018)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
por: Long, Junyu, et al.
Publicado: (2021)

Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
por: Long, Junyu, et al.
Publicado: (2021)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
por: Long, Junyu, et al.
Publicado: (2022)

Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
por: Deng, Kaige, et al.
Publicado: (2023)

Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019)

Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma
por: Fan, Hongxia, et al.
Publicado: (2017)

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors is the treatment option of previously treated advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
por: Yang, Xiaobo, et al.
Publicado: (2022)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
por: Zhu, Chengpei, et al.
Publicado: (2023)

Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
por: Wang, Anqiang, et al.
Publicado: (2018)

A four‐gene‐based prognostic model predicts overall survival in patients with hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2018)

Perioperative management of patients with liver cancer complicated with sarcopenia
por: Xing, Jiali, et al.
Publicado: (2022)

Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing
por: Zhang, Xu, et al.
Publicado: (2019)

dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers
por: Yang, Zhen, et al.
Publicado: (2017)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Tea consumption and the risk of biliary tract cancer: a systematic review and dose–response meta-analysis of observational studies
por: Xiong, Jianping, et al.
Publicado: (2017)

Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management
por: Yang, Xu, et al.
Publicado: (2023)

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
por: Zhu, Chengpei, et al.
Publicado: (2023)

Safety, feasibility, and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma: a systematic review
por: Zhang, Junwei, et al.
Publicado: (2020)

Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma
por: Gong, Xianli, et al.
Publicado: (2016)

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0aht2csbhd3r7rs5mti5qmdke